Sphingotec reports new applications of bio-ADM at 39th ISICEM

[News]

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

More... (https://www.news-medical.net/news/20190320/Sphingotec-reports-new-applications-of-bio-ADM-at-39th-ISICEM.aspx)